Werewolf Therapeutics, Inc. (HOWL) stock forecast and price target
Price $0.98 · data as of November 13, 2026
12-month price target
Average target$7.00
Upside / downside+614.1%
Analysts3
ConsensusNone
Low $4.00Average $7.00High $10.00
Gold marker: average target · white marker: today’s price ($0.98)
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.89 | +32.6% | $0 |
| Next fiscal year ends December 31, 2027 | $-0.59 | +33.7% | $0 |
| Next quarter ends December 31, 2026 | $-0.17 | +0.0% | $0 |
Consensus of the analysts covering Werewolf Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Werewolf Therapeutics stock price target?
The average 12-month target from 3 analysts is $7.00, 614.1% above the current price of $0.98 Targets range from $4.00 to $10.00.
Is Werewolf Therapeutics a buy according to analysts?
The consensus rating is “None”. Ratings are opinions, not guarantees; this is not investment advice.
How much is Werewolf Therapeutics expected to earn?
Analysts expect EPS of $-0.89 for the fiscal year ending December 31, 2026 and $-0.59 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.